Providing market intelligence for more than 35 years

In The News

Roku, Chromecast top streaming device purchases, usage, research firms find

Online video streaming devices are present in 21 percent of U.S. homes, a 13 percent increase over the past year, new research from The Diffusion Group has found. Further, a Parks Associates study revealed that four brands make up 86 percent of all streaming devices sold: Amazon (NASDAQ: AMZN), Apple (NASDAQ: AAPL), Google (NASDAQ: GOOG) and Roku.

"Roku continues to lead streaming media device sales in the U.S. with 34 percent of units sold in 2014. Google is second with 23 percent, and new entrant Amazon overtook Apple for third place," said Barbara Kraus, director of research at Parks.

Additionally, Roku is tops when it comes to usage, at 37 percent. Google's Chromecast came in a distant second in usage at 19 percent.

From the article "Roku, Chromecast top streaming device purchases, usage, research firms find" by Samantha Bookman.

Previously In The News

Parks: US Churn Rate For OTT Services Is 19%

This is according to Parks Associates’ latest ‘OTT Video Market Tracker’ stats, which said that overall churn rate for OTT services has been roughly stable for the past year. At the end of 2015, 20...

One in five US subscribers now ‘dissatisfied’ with pay TV service

Some 20% of US pay TV subscribers are now dissatisfied with their pay TV service, according to research from Parks Associates. The future represents a 100% increase since 2013, according to Parks....

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...